224 related articles for article (PubMed ID: 29262322)
1. SRSF1 Prevents DNA Damage and Promotes Tumorigenesis through Regulation of DBF4B Pre-mRNA Splicing.
Chen L; Luo C; Shen L; Liu Y; Wang Q; Zhang C; Guo R; Zhang Y; Xie Z; Wei N; Wu W; Han J; Feng Y
Cell Rep; 2017 Dec; 21(12):3406-3413. PubMed ID: 29262322
[TBL] [Abstract][Full Text] [Related]
2. Splicing factor SRSF1 promotes gliomagenesis via oncogenic splice-switching of MYO1B.
Zhou X; Wang R; Li X; Yu L; Hua D; Sun C; Shi C; Luo W; Rao C; Jiang Z; Feng Y; Wang Q; Yu S
J Clin Invest; 2019 Feb; 129(2):676-693. PubMed ID: 30481162
[TBL] [Abstract][Full Text] [Related]
3. BCLAF1 and its splicing regulator SRSF10 regulate the tumorigenic potential of colon cancer cells.
Zhou X; Li X; Cheng Y; Wu W; Xie Z; Xi Q; Han J; Wu G; Fang J; Feng Y
Nat Commun; 2014 Aug; 5():4581. PubMed ID: 25091051
[TBL] [Abstract][Full Text] [Related]
4. SRPK1/2 and PP1α exert opposite functions by modulating SRSF1-guided MKNK2 alternative splicing in colon adenocarcinoma.
Liu H; Gong Z; Li K; Zhang Q; Xu Z; Xu Y
J Exp Clin Cancer Res; 2021 Feb; 40(1):75. PubMed ID: 33602301
[TBL] [Abstract][Full Text] [Related]
5. SRSF1-Regulated Alternative Splicing in Breast Cancer.
Anczuków O; Akerman M; Cléry A; Wu J; Shen C; Shirole NH; Raimer A; Sun S; Jensen MA; Hua Y; Allain FH; Krainer AR
Mol Cell; 2015 Oct; 60(1):105-17. PubMed ID: 26431027
[TBL] [Abstract][Full Text] [Related]
6. The RNA-binding protein SRSF1 is a key cell cycle regulator via stabilizing NEAT1 in glioma.
Zhou X; Li X; Yu L; Wang R; Hua D; Shi C; Sun C; Luo W; Rao C; Jiang Z; Wang Q; Yu S
Int J Biochem Cell Biol; 2019 Aug; 113():75-86. PubMed ID: 31200124
[TBL] [Abstract][Full Text] [Related]
7. RNA splicing is a key mediator of tumour cell plasticity and a therapeutic vulnerability in colorectal cancer.
Hall AE; Pohl SÖ; Cammareri P; Aitken S; Younger NT; Raponi M; Billard CV; Carrancio AB; Bastem A; Freile P; Haward F; Adams IR; Caceres JF; Preyzner P; von Kriegsheim A; Dunlop MG; Din FV; Myant KB
Nat Commun; 2022 May; 13(1):2791. PubMed ID: 35589755
[TBL] [Abstract][Full Text] [Related]
8. SRSF1 inhibits autophagy through regulating Bcl-x splicing and interacting with PIK3C3 in lung cancer.
Lv Y; Zhang W; Zhao J; Sun B; Qi Y; Ji H; Chen C; Zhang J; Sheng J; Wang T; Dominguez D; Liu H; Liu Q; Meng S; Li X; Wang Y
Signal Transduct Target Ther; 2021 Mar; 6(1):108. PubMed ID: 33664238
[TBL] [Abstract][Full Text] [Related]
9. SRSF1 modulates PTPMT1 alternative splicing to regulate lung cancer cell radioresistance.
Sheng J; Zhao Q; Zhao J; Zhang W; Sun Y; Qin P; Lv Y; Bai L; Yang Q; Chen L; Qi Y; Zhang G; Zhang L; Gu C; Deng X; Liu H; Meng S; Gu H; Liu Q; Coulson JM; Li X; Sun B; Wang Y
EBioMedicine; 2018 Dec; 38():113-126. PubMed ID: 30429088
[TBL] [Abstract][Full Text] [Related]
10. Splicing Factor SRSF1 Promotes Pancreatitis and KRASG12D-Mediated Pancreatic Cancer.
Wan L; Lin KT; Rahman MA; Ishigami Y; Wang Z; Jensen MA; Wilkinson JE; Park Y; Tuveson DA; Krainer AR
Cancer Discov; 2023 Jul; 13(7):1678-1695. PubMed ID: 37098965
[TBL] [Abstract][Full Text] [Related]
11. AMP-activated protein kinase regulates alternative pre-mRNA splicing by phosphorylation of SRSF1.
Matsumoto E; Akiyama K; Saito T; Matsumoto Y; Kobayashi KI; Inoue J; Yamamoto Y; Suzuki T
Biochem J; 2020 Jun; 477(12):2237-2248. PubMed ID: 32453427
[TBL] [Abstract][Full Text] [Related]
12. Splicing events in the control of genome integrity: role of SLU7 and truncated SRSF3 proteins.
Jiménez M; Urtasun R; Elizalde M; Azkona M; Latasa MU; Uriarte I; Arechederra M; Alignani D; Bárcena-Varela M; Álvarez-Sola G; Colyn L; Santamaría E; Sangro B; Rodriguez-Ortigosa C; Fernández-Barrena MG; Ávila MA; Berasain C
Nucleic Acids Res; 2019 Apr; 47(7):3450-3466. PubMed ID: 30657957
[TBL] [Abstract][Full Text] [Related]
13. Splicing factor SRSF1 negatively regulates alternative splicing of MDM2 under damage.
Comiskey DF; Jacob AG; Singh RK; Tapia-Santos AS; Chandler DS
Nucleic Acids Res; 2015 Apr; 43(8):4202-18. PubMed ID: 25845590
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of alternative splicing contributes to multiple myeloma pathogenesis.
Song S; Zhang W; Li Q; Wang Z; Su Q; Zhang X; Li B; Zhuang W
Br J Cancer; 2023 Apr; 128(6):1086-1094. PubMed ID: 36593359
[TBL] [Abstract][Full Text] [Related]
15. CircSMARCA5 Inhibits Migration of Glioblastoma Multiforme Cells by Regulating a Molecular Axis Involving Splicing Factors SRSF1/SRSF3/PTB.
Barbagallo D; Caponnetto A; Cirnigliaro M; Brex D; Barbagallo C; D'Angeli F; Morrone A; Caltabiano R; Barbagallo GM; Ragusa M; Di Pietro C; Hansen TB; Purrello M
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29415469
[TBL] [Abstract][Full Text] [Related]
16. Splicing factor SRSF1 deficiency in the liver triggers NASH-like pathology and cell death.
Arif W; Mathur B; Saikali MF; Chembazhi UV; Toohill K; Song YJ; Hao Q; Karimi S; Blue SM; Yee BA; Van Nostrand EL; Bangru S; Guzman G; Yeo GW; Prasanth KV; Anakk S; Cummins CL; Kalsotra A
Nat Commun; 2023 Feb; 14(1):551. PubMed ID: 36759613
[TBL] [Abstract][Full Text] [Related]
17. Eucalyptal A inhibits glioma by rectifying oncogenic splicing of MYO1B mRNA via suppressing SRSF1 expression.
Hua D; Zhao Q; Yu Y; Yu H; Yu L; Zhou X; Wang Q; Sun C; Shi C; Luo W; Jiang Z; Wang W; Wang L; Zhang D; Tang S; Yu S
Eur J Pharmacol; 2021 Jan; 890():173669. PubMed ID: 33098832
[TBL] [Abstract][Full Text] [Related]
18. SRSF3, a Splicer of the PKM Gene, Regulates Cell Growth and Maintenance of Cancer-Specific Energy Metabolism in Colon Cancer Cells.
Kuranaga Y; Sugito N; Shinohara H; Tsujino T; Taniguchi K; Komura K; Ito Y; Soga T; Akao Y
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30279379
[TBL] [Abstract][Full Text] [Related]
19. SRSF1 and RBM4 differentially modulate the oncogenic effect of HIF-1α in lung cancer cells through alternative splicing mechanism.
Chang HL; Lin JC
Biochim Biophys Acta Mol Cell Res; 2019 Dec; 1866(12):118550. PubMed ID: 31491447
[TBL] [Abstract][Full Text] [Related]
20. SRSF1 interactome determined by proximity labeling reveals direct interaction with spliceosomal RNA helicase DDX23.
Segovia D; Adams DW; Hoffman N; Safaric Tepes P; Wee TL; Cifani P; Joshua-Tor L; Krainer AR
Proc Natl Acad Sci U S A; 2024 May; 121(21):e2322974121. PubMed ID: 38743621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
